The new role of TYMS in intracellular antioxidant function suggests that TYMS and Nrf2 could be used as a valuable target to improve the clinical efficacy in ESCC chemotherapy. The gene discussed is NFE2L2; the disease is esophageal squamous cell carcinoma.